$600M in prizes drove $30B in R&D
XPRIZE has launched $600 million worth of prize competitions and catalyzed approximately $30 billion in R&D investment as a result.
Snapshot · Moonshots with Peter Diamandis
Michael Kratsios on the New Golden Age of American Science | EP #276
Explore episode
Aug 4, 2026
Where this was said
Prizes, XPRIZE, and the Future of Pay-for-Results Science
At 47:23 · chapter starts 45:55
With the Golden Age Report explicitly endorsing prize challenges and advanced market commitments, Peter steps into his home turf: over 30 years, XPRIZE has launched $600 million in prize competitions and driven approximately $30 billion in R&D — a roughly 50:1 leverage ratio on prize capital. He pitches Kratsios on the idea of 10 $1 billion prizes focused on the nation's most important challenges, including one targeting longevity. Kratsios is enthusiastic but pragmatic: the federal budget can absorb prizes in the $100 million range for sufficiently significant challenges, but $1 billion for a single prize is a stretch for the current fiscal environment. Peter then introduces the $101 million XPRIZE Healthspan — the organization's largest-ever prize, with 830 competing teams — as an example of what's achievable, arguing that reversing aging by 20 functional years would be the single highest-impact intervention on the US economy.
XPRIZE and the Power of Prizes: $600M That Drove $30B in R&D
XPRIZE has launched $600 million in prizes and catalyzed $30 billion in R&D. The Golden Age Report explicitly endorses prize challenges, advanced market commitments, and pay-for-results models as alternatives to traditional grants — with the administration eyeing prizes in the $100 million range for major national challenges.
US spends ~$200B/year on R&D
The US federal government spends approximately $200 billion per year on R&D, with roughly $45 billion of that at NIH for biomedical research.
XPRIZE Healthspan: $101M, 830 teams
The XPRIZE Healthspan competition is a $101 million prize with 830 competing teams, aiming to reverse functional age by 20 years.
Similar snapshots
Ego depletion research failed to replicate
The widely cited ego-depletion model — the idea that willpower is a finite resource that gets depleted — failed to replicate in follow-up studies.
5,000–7,000 thoughts per day; recall ≈ 0
Humans are estimated to have 5,000–7,000 thoughts per day, yet can recall essentially none of them afterward, highlighting why in-the-moment emotional tracking matters.
Wandering mind = unhappy mind (Harvard study)
A large Harvard study found that a wandering mind is an unhappy mind — people report greater happiness when their attention is tethered to the present, even if the task is unpleasant.
Microplastic overestimate: gloves contaminated tests
A key study finding that we have a 'credit card's worth of plastic' in our bodies was likely skewed because researchers used nitrile gloves that shed plastic particles onto the microplastic detector.
Hyperactive amygdala + frayed PFC link
Emotionally sensitive people have a hyperactive amygdala, an underactive prefrontal cortex, and a frayed connection between the two — making emotional regulation structurally harder.
RSD visible in children as young as 2–3 years old
Rejection sensitivity can be observed as early as age 2 or 3, suggesting it has strong developmental and likely genetic roots.
Mindfulness reduces brain activation — Yale study
A Yale study found that non-judgmental observation of emotions — without rushing to resolve them — reduces activation in the brain, making it a powerful regulation tool.
Psychological immune system works strongest on irreversible decisions
Dan Gilbert's research found that the psychological immune system — the brain's ability to justify and find satisfaction in choices — activates most powerfully when a decision is perceived as irreversible.
Maximizers earn more but are less happy than satisficers
Barry Schwartz's research found that maximizers — people who try to optimize every decision — tend to achieve objectively better outcomes but report lower happiness than satisficers who choose 'good enough.'
